Omega Fund Management »

Imagenebio shares owned by Omega Fund Management

Quarter-by-quarter ownership of Imagenebio shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Imagenebio

Tip: Access up to 7 years of quarterly data

All positions including Imagenebio held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Imagenebio by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 455k 8.15

More positions owned by Omega Fund Management

Kestra Med Technologies Common Stock (KMTS)
Beta Bionics Common Stock (BBNX)
BridgeBio Oncology Therapeutics Common Stock
Bicara Therapeutics Common Stock (BCAX)
Nuvation Bio Common Stock Class A (NUVB)
Upstream Bio Common Stock (UPB)
ImageneBio Common Stock
enGene Holdings Common Stock (ENGN)
Sana Biotechnology Common Stock (SANA)
Alumis Common Stock (ALMS)
Replimune Group Common Stock (REPL)
enGene Holdings Warrant (ENGNW)

View all positions for Omega Fund Management

Top funds holding Imagenebio

Deep Track Capital
BVF
Blue Owl Capital Holdings
Omega Fund Management
OrbiMed Advisors
Atlas Venture Life Science Advisors
Rtw Investments
Vanguard Group
BML Capital Management
Citadel Advisors
Adage Capital Partners GP
BlackRock
NEA Management Company
Geode Capital Management
XTX Topco

View all funds holding Imagenebio